Asthra Health offers physician‑led precision medicine services for patients with advanced cancers, complex neurological disorders, and refractory autoimmune conditions. Leveraging detailed record review, molecular and biomarker analysis, the practice creates individualized treatment roadmaps that include off‑label targeted therapies, clinical trial enrollment, and compassionate‑use access, while handling insurance and logistics coordination.
Funding
Funding not disclosed
Founders
Product
Problem
Patients with complex brain tumors, advanced cancers, rare neurological disorders, or refractory autoimmune conditions often face fragmented care, limited access to targeted therapies, and difficulty navigating clinical trials or expanded‑access programs.
Solution
Asthra Health provides physician‑led precision medicine services that integrate detailed record review, molecular and biomarker analysis, and advanced analytics to generate individualized treatment roadmaps. Under the guidance of Dr. Santosh Kesari, the practice coordinates off‑label targeted agents, clinical trial enrollment, and compassionate‑use applications while collaborating with the patient’s existing care team. The service also offers ongoing navigation support for insurance appeals, infusion logistics, and longitudinal monitoring, enabling patients to access cutting‑edge therapies without the administrative burden.
Target Audience
Primary customers are patients with high‑risk or refractory brain tumors, advanced cancers, complex neurological disorders, or immune‑mediated diseases, as well as their referring oncologists, neurologists, and rheumatologists seeking expert second opinions and precision treatment pathways.
Features
- Comprehensive review of imaging, pathology, genomic and CSF biomarker data to identify actionable targets
- Personalized treatment plans that include off‑label targeted drugs, immunotherapies, and stem‑cell or gene‑based approaches
- Coordination of clinical trial eligibility assessment and enrollment, including biomarker‑driven matching
- FAST TRACK™ Compassionate Access program to secure expanded‑access (EAP) use of investigational agents
- Insurance appeal assistance and cash‑pay infusion logistics to reduce financial and administrative barriers
- Integrated patient portal for secure document upload, visit summaries, and ongoing communication with the care team
- Ongoing longitudinal care options, from one‑time consultations to subscription‑based follow‑up and monitoring